Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Dec 16, 2016 2:21pm
312 Views
Post# 25611542

RE:Not just retail sellers

RE:Not just retail sellersBepando I gave you 5 stars.  I think you have the right take on the situation.  Also, as another post suggested, the TST takeover did not work out in our favor.  The bottom line for the year 2016 is that PLI has promised a lot but they have not delivered YET. Yes, they are working hard and have a great pipeline but the share price is lower today than last December. You can't blames funds for wanting to unload. People do look at fund holdings and results. PLI looks like a real loser, better to make it disappear. Yes, they will return in 2017 at some point...
Bullboard Posts